Fundraising FoxCalimmune
AcquiredTucson, US · Delaware corporation · 3 known investors
Find your way into Calimmune
Sign up to see every warm intro you have to Calimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by CSL Behring August 2017 · $91M ($91 million upfront plus up to $325 million in milestone payments) · source ↗
Calimmune was a Tucson-based biotech founded in 2006 from David Baltimore's research that developed ex vivo gene- and stem-cell-therapy technologies, including an HIV treatment (CAL-1) and a sickle-cell/beta-thalassemia therapy (CAL-H).
Founders & leadership
Board
Investors · 3
How we know: Cycad Group LLC's portfolio page · Not right? Tell us
How we know: RA Capital's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.9M disclosed across 1 round · 2015
▶$15.9MraisedMay 2015 · 51 investors · BiotechnologyRule 506(b)
- Peter KolchinskyDirector
- Jon Faiz Kayyem, Ph.D.Director
- Louis BretonExecutive Officer, Director
- David Baltimore, Ph.D.Director
- Harry A. GeorgeDirector
- Bhavin RavalExecutive Officer
- David H. Donabedian, Ph.D.Director
- Offering amount
- $16M
- Amount sold
- $15.9M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Calimmune do?
- Calimmune was a Tucson-based biotech founded in 2006 from David Baltimore's research that developed ex vivo gene- and stem-cell-therapy technologies, including an HIV treatment (CAL-1) and a sickle-cell/beta-thalassemia therapy (CAL-H).
- Who founded Calimmune?
- Calimmune was founded by Louis Breton, David Baltimore, Ph.D..
- Who are Calimmune's investors?
- Calimmune's investors include Cycad Group LLC, RA Capital, Alexandria.
- How much funding has Calimmune raised?
- Calimmune has disclosed $15.9M raised across 1 round.
- Where is Calimmune headquartered?
- Calimmune is headquartered in Tucson, US.